19 October-1 December 2020
The 51st Union World Conference On Lung Health
REGISTER NOW

Sessions

All Sessions
keyboard_arrow_down
keyboard_arrow_down Show filters keyboard_arrow_up Hide filters
  • All Tracks
  • Community Connect
  • Channel 1
  • Channel 2
  • Channel 3
  • Channel 4
  • Channel 5
  • Channel 6
  • Channel 7
  • E-posters
  • Workshops
Channel 1
P1-Prevention supports cure
event_note
Loading...
query_builder 14:00 - 15:00 | Event time (GMT+2)
query_builder - | Your time (GMT)
place Online Session/Virtual
card_travel Plenary session
mic English
P1-Prevention supports cure
*Please scroll down for more information*
Historically TB services and approaches have focused on finding and treating people who have active TB disease, who may be at risk of transmitting TB to their immediate contacts and community. However, there are tools that have been available to TB programmes for a number of decades that can prevent TB disease – TB vaccine and TB preventative therapies. Yet, despite these preventative tools, 10 million people a year still develop TB disease.
This plenary will discuss how TB prevention tools continue to improve and how to ensure that as new tools are developed the appropriate health system strengthening and policies on Universal Health care can be undertaken so they are implemented without compromising the treatment and care of TB disease.

14:00 - 14:03: Session introduction


14:03 - 14:18: P1A-Vaccines: 100 years since BCG - where are we now?

Helen McShane

14:18 - 14:33: PL1B-Lessons for TB preventive therapy implementation

Rovina Ruslami

14:33 - 14:48: PL1C-The truth about being TB Proof

Arne von Delft

14:48 - 14:58: PL1D-Moderated discussion

Helen McShane
Rovina Ruslami
Arne von Delft

Loading...
Channel 1
SS1-Sars-CoV2 - the hope for a vaccine
event_note
Loading...
query_builder 15:00 - 16:20 | Event time (GMT+2)
query_builder - | Your time (GMT)
place Online Session/Virtual
card_travel Special session
mic English
SS1-Sars-CoV2 - the hope for a vaccine
*Please scroll down for more information*
Since the SARS-CoV-2 virus was identified in December 2019, over 37 million people have been infected, and over 1 million deaths have been reported worldwide. Our hopes have been largely focused on the development of a preventative vaccine. But data suggests that immunity may be short lived following infection raises many questions and possible challenges for vaccine development.

15:00 - 15:05: Session introduction


15:05 - 15:20: COVID19 - Public health and scientific challenges

Anthony Fauci

15:20 - 15:30: The COVID19 vaccine portfolio

Vasee Moorthy

15:30 - 15:40: How do we ensure equitable global access to COVID-19 vaccines?

Suerie Moon

15:40 - 15:50: Vaccine hesitancy: until we understand public opinion, we cannot hope to change it

Jeffrey Lazarus

15:50 - 16:00: Going from efficacy trials to public health intervention

Kate O'Brien

16:00 - 16:25: Live Q&A and moderated discussion

Vasee Moorthy
Kate O'Brien
Suerie Moon
Jeffrey Lazarus

Loading...
Channel 1
P2-COVID-19: Major disrupter, new opportunities
event_note
Loading...
query_builder 14:00 - 15:00 | Event time (GMT+2)
query_builder - | Your time (GMT)
place Online Session/Virtual
card_travel Plenary session
mic English
P2-COVID-19: Major disrupter, new opportunities
*Please scroll down for more information*
With over 36 million cases and 1 million deaths in early October, the COVID-19 pandemic, caused by the novel corona virus SARSCoV-2, brought the world to a halt in early 2020. Cities and countries retreated into varying degrees of social lockdown, economies plummeted and the medical and scientific fraternities scrambled to prepare and to uncover treatments and prevention strategies. How might we have been better prepared? What can we learn from our responses? And how can we use this opportunity to address historical inequalities that have been thrown into relief during this time?

14:00 - 14:03: Session introduction


14:03 - 14:18: PL2A-Lessons from the past and present for future pandemics

Michael T. Osterholm

14:18 - 14:23: PL2B-Global response to COVID-19

Maria Van Kerkhove

14:23 - 14:33: Impact of COVID pandemic on health care priorities and programmes

Madhukar Pai

14:33 - 14:48: PL2C-Human rights issues exposed

Allan Maleche

14:48 - 14:58: PL2D-Moderated panel discussion

Michael T. Osterholm
Madhukar Pai
Allan Maleche

Loading...
Channel 1
SS2-COVID-19: different strokes
event_note
Loading...
query_builder 15:00 - 16:20 | Event time (GMT+2)
query_builder - | Your time (GMT)
place Online Session/Virtual
card_travel Special session
mic English
SS2-COVID-19: different strokes
*Please scroll down for more information*
While SARS-CoV2 has spread across the world, countries’ responses have varied around the globe. This session will focus on the different approaches and the impact of these strategies on country statistics and experiences. The discussion will include the reasons for different strategies (including lessons learned from other epidemics), the pros and cons of these approaches and the possible translational lessons for tackling other epidemics.

15:00 - 15:03: Introduction


15:03 - 15:13: Turkey: targeted mitigation

Kayihan Pala

15:13 - 15:23: Senegal: be prepared

Abdoulaye Bousso

15:23 - 15:33: South Africa: Early lockdown

Glenda Gray

15:33 - 15:43: Brazil: Missed opportunities

Guilherme Werneck

15:43 - 15:53: New Zealand: Elimination strategy

Ayesha Verrall

15:53 - 16:03: Australia: Adaptability

Jodie McVernon

16:03 - 16:13: A personal experience

Robin Gorna

16:13 - 16:28: Live Q&A and moderated discussion

Kayihan Pala
Abdoulaye Bousso
Glenda Gray
Guilherme Werneck
Jodie McVernon
Robin Gorna

Loading...
Channel 5
SS3-UN HLM TB goals – are we on track?
event_note
Loading...
query_builder 12:30 - 13:50 | Event time (GMT+2)
query_builder - | Your time (GMT)
place Online Session/Virtual
card_travel Special session
mic English
SS3-UN HLM TB goals – are we on track?
*Please scroll down for more information*
In 2018, heads of state committed to global TB targets in the United Nations High-Level Meeting’s Political Declaration on TB. Targets included: to treat 40 million people with TB, 3.5 million children with TB, 1.5 million people with drug-resistant TB and for at least 30 million to be put on TB preventive treatment – all to be achieved by 2022. At the half way mark to this deadline, it is prudent to assess our progress and evaluate the challenges to success.

12:30 - 12:33: Session introduction


12:33 - 12:43: Taking forward the commitments of the first United Nations high-level meeting on TB

Tereza Kasaeva

12:43 - 12:53: Successes and challenges driving country-level political commitment

Angelina 'Helen' Tan

12:53 - 13:03: How do we assess and demand accountability?

Tushar Nair

13:03 - 13:13: Grassroots voice

Blessina Kumar

13:13 - 13:28: Live moderated panel discussion


Loading...
Channel 1
P3-Striving for Universal Health Coverage
event_note
Loading...
query_builder 14:00 - 15:00 | Event time (GMT+2)
query_builder - | Your time (GMT)
place Online Session/Virtual
card_travel Plenary session
mic English
P3-Striving for Universal Health Coverage
*Please scroll down for more information*
Universal health coverage (UHC) is built on the principles that all people have access to the health services they need, without financial hardship. This includes the availability of and access to a full range of essential health services, from health promotion to prevention, treatment, rehabilitation, and palliative care.  Currently, at least half of the people in the world do not receive the health services they need. About 100 million people are pushed into extreme poverty each year because of out-of-pocket spending on health. This must change.
To move toward the goal of Universal Health Coverage it is necessary to develop resilient, responsive and inclusive health systems based on strong, people-centred primary health care, informed by the best available evidence and civil society and vulnerable communities at the heart of the response.
As the largest health profession in the global health workforce, nurses are intrinsically linked and well placed to play a key role in achieving Universal Health Coverage and the Sustainable Development Goals. Working across the life course and in all settings nurses are often the first and only point of care in their communities. They work to uphold human rights, fight to reduce inequalities and empower people and communities.  Civil Society similarly has a key role to play in achieving the goal of Universal Health Coverage: to ensure that the community’s needs in relation to access to, and the delivery of health services are met.  Community voices need to be amplified as they have a critical leadership role in decision making and accountability for UHC.
(UHC- "Empower individuals, families, communities, local providers and civil society organisations to be at the centre of UHC, especially by strengthening and enhancing community capacity to get involved in decision-making and accountability processes")

14:00 - 14:03: Session introduction


14:03 - 14:18: PL3A-The multifaceted role of nurses in universal health coverage

Elizabeth Iro

14:18 - 14:33: PL3B-Access to care: how do we tackle the gaps?

Erika Mohr-Holland

14:33 - 14:43: PL3C-A personal tale

Prachi Kathuria

14:43 - 14:53: PL3D-Moderated panel discussion


Loading...
Channel 7
SS4-What can we do to mitigate zoonotic infection risk?
event_note
Loading...
query_builder 12:30 - 13:50 | Event time (GMT+2)
query_builder - | Your time (GMT)
place Online Session/Virtual
card_travel Special session
mic English
SS4-What can we do to mitigate zoonotic infection risk?
*Please scroll down for more information*
Over just the last 10 years, we have experienced zoonotic disease outbreaks that have had, and are still having, a considerable impact on both animal and human populations. As we are becoming more adept at understanding how to contain and combat disease spread, we recognise that prevention and mitigation starts with animals. Amidst an outbreak it is often human vaccines that seem like the logical area of focus for control yet, ultimately, animal vaccines can be as effective and, in the case of rabies, more effective at slowing the spread. Thus, scientists from the worlds of animal, human and environmental health are beginning to work together more to share knowledge so we can better understand infectious diseases and how they jump from animals to humans. More than 60% of emerging infectious diseases are zoonotic, so keeping animals in good health can be our first line of defence in helping keep outbreaks under control.

12:30 - 12:35: Session introduction


12:35 - 12:45: Zika in Brazil, edidemic spread, consequences for human health and the environment

Jose Eduardo Levi

12:45 - 12:55: SARS-CoV-2 in mink, experiences from the field

Robert Jan Molenaar

12:55 - 13:05: Successful Zika community control programmes in an endemic area

Marianyoly Ortiz

13:05 - 13:15: Community perspective

Timpiyian Leseni

13:15 - 13:45: Live Q&A and moderated discussion


Loading...
Channel 1
P4-Greed, smoke and lung health
event_note
Loading...
query_builder 14:00 - 15:00 | Event time (GMT+2)
query_builder - | Your time (GMT)
place Online Session/Virtual
card_travel Plenary session
mic English
P4-Greed, smoke and lung health
*Please scroll down for more information*
The adverse impact of natural disasters, practices such as deforestation and agricultural burning and man-made products such as tobacco and nicotine on environmental determinants of health, such as clean air, cannot be ignored.  And yet, industries profiting from these practices and products continue business as usual with minimal consideration of these problems.  “Reduced Risk Products” are presented as safer alternatives to cigarettes. Ineffective and insufficient methods to mitigate climate crisis are proposed – delaying meaningful action.  The fight for lung health must include addressing these major contributors to lung health issues in an effective manner, to protect the health of all people, in particular the most vulnerable.

14:00 - 14:03: Session introduction


14:03 - 14:18: PL4A-New generation tobacco and nicotine products: are they harmless?

Jorgen Vestbo

14:18 - 14:33: PL4B-Landscape fires, smoke, and lung health

Fay Johnston

14:33 - 14:48: PL4C-Outdoor and household air pollution - the personal cost

Elvis Ndikum Achiri

14:48 - 14:58: PL4D-Moderated panel discussion


Loading...
Processing. Please wait.
Loading...